 | • レポートコード：QYR2104Z0986 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、画期的治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、抗ウイルス剤、神経、その他）、用途別市場規模（病院、クリニック、外来サービス）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・画期的治療薬の市場動向 ・企業の競争状況、市場シェア ・画期的治療薬の種類別市場規模（腫瘍、抗ウイルス剤、神経、その他） ・画期的治療薬の用途別市場規模（病院、クリニック、外来サービス） ・画期的治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・画期的治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・画期的治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・画期的治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・画期的治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Pfizer、AbbVie、Bristol-Myers Squibb Company、Genentech、Gilead、Novartis、Vertex Pharmaceuticals Incorporated） ・結論 |
Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two factors determine the efficiency of breakthrough therapy drug, they are the magnitude of the treatment effect and observed clinical difference over the existed drug. The standard for breakthrough therapy drug is not same as standard drug approval because, in breakthrough therapy, morbidity and mortality considered for approval of the drug. They are meant to be administered by itself or in combinations. Breakthrough therapy drug development is cost effective due to faster approval of drugs on limited data from the FDA. Manufacturer of breakthrough therapy drugs has to develop additional post-marketing surveillance data for the other reimbursements and market access. Presently available breakthrough therapy medicinal products in the market belong to the treatment class of oncology, infectious diseases, cardiovascular conditions, etc. The designation is given when the drug is in 1st or 2nd stage of clinical trials.
Increasing prevalence of life-threatening conditions and for the speedy development of pipeline drugs is the primary driver for the breakthrough therapy drugs market. This is because of the high unmet need of presently available treatment for severe conditions. Breakthrough designation of the drug captures the more attention of the manufacturers due to the expedited market access and greater returns on their investments. Because of Breakthrough therapy drugs market are associated with less robust clinical developments. Increasing support of FDA for small scale industries in R&D by providing additional funding and faster approval of drugs fuelling the growth of the breakthrough therapy drugs market. All these factors are boosting the growth of the breakthrough therapy drug market.
Market Analysis and Insights: Global Breakthrough Therapy Drugs Market
The global Breakthrough Therapy Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breakthrough Therapy Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breakthrough Therapy Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breakthrough Therapy Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breakthrough Therapy Drugs market.
Global Breakthrough Therapy Drugs Scope and Market Size
Breakthrough Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breakthrough Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oncology
Anti-Viral
Neurology
Others
Segment by Application
Hospitals
Clinics
Ambulatory Services
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Pfizer
AbbVie
Bristol-Myers Squibb Company
Genentech
Gilead
Novartis
Vertex Pharmaceuticals Incorporated
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oncology
1.2.3 Anti-Viral
1.2.4 Neurology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Breakthrough Therapy Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Services
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breakthrough Therapy Drugs Market Perspective (2016-2027)
2.2 Breakthrough Therapy Drugs Growth Trends by Regions
2.2.1 Breakthrough Therapy Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breakthrough Therapy Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Breakthrough Therapy Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Breakthrough Therapy Drugs Industry Dynamic
2.3.1 Breakthrough Therapy Drugs Market Trends
2.3.2 Breakthrough Therapy Drugs Market Drivers
2.3.3 Breakthrough Therapy Drugs Market Challenges
2.3.4 Breakthrough Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breakthrough Therapy Drugs Players by Revenue
3.1.1 Global Top Breakthrough Therapy Drugs Players by Revenue (2016-2021)
3.1.2 Global Breakthrough Therapy Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Breakthrough Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breakthrough Therapy Drugs Revenue
3.4 Global Breakthrough Therapy Drugs Market Concentration Ratio
3.4.1 Global Breakthrough Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy Drugs Revenue in 2020
3.5 Breakthrough Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Breakthrough Therapy Drugs Product Solution and Service
3.7 Date of Enter into Breakthrough Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakthrough Therapy Drugs Breakdown Data by Type
4.1 Global Breakthrough Therapy Drugs Historic Market Size by Type (2016-2021)
4.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2022-2027)
5 Breakthrough Therapy Drugs Breakdown Data by Application
5.1 Global Breakthrough Therapy Drugs Historic Market Size by Application (2016-2021)
5.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breakthrough Therapy Drugs Market Size (2016-2027)
6.2 North America Breakthrough Therapy Drugs Market Size by Type
6.2.1 North America Breakthrough Therapy Drugs Market Size by Type (2016-2021)
6.2.2 North America Breakthrough Therapy Drugs Market Size by Type (2022-2027)
6.2.3 North America Breakthrough Therapy Drugs Market Size by Type (2016-2027)
6.3 North America Breakthrough Therapy Drugs Market Size by Application
6.3.1 North America Breakthrough Therapy Drugs Market Size by Application (2016-2021)
6.3.2 North America Breakthrough Therapy Drugs Market Size by Application (2022-2027)
6.3.3 North America Breakthrough Therapy Drugs Market Size by Application (2016-2027)
6.4 North America Breakthrough Therapy Drugs Market Size by Country
6.4.1 North America Breakthrough Therapy Drugs Market Size by Country (2016-2021)
6.4.2 North America Breakthrough Therapy Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Breakthrough Therapy Drugs Market Size (2016-2027)
7.2 Europe Breakthrough Therapy Drugs Market Size by Type
7.2.1 Europe Breakthrough Therapy Drugs Market Size by Type (2016-2021)
7.2.2 Europe Breakthrough Therapy Drugs Market Size by Type (2022-2027)
7.2.3 Europe Breakthrough Therapy Drugs Market Size by Type (2016-2027)
7.3 Europe Breakthrough Therapy Drugs Market Size by Application
7.3.1 Europe Breakthrough Therapy Drugs Market Size by Application (2016-2021)
7.3.2 Europe Breakthrough Therapy Drugs Market Size by Application (2022-2027)
7.3.3 Europe Breakthrough Therapy Drugs Market Size by Application (2016-2027)
7.4 Europe Breakthrough Therapy Drugs Market Size by Country
7.4.1 Europe Breakthrough Therapy Drugs Market Size by Country (2016-2021)
7.4.2 Europe Breakthrough Therapy Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breakthrough Therapy Drugs Market Size (2016-2027)
8.2 Asia-Pacific Breakthrough Therapy Drugs Market Size by Type
8.2.1 Asia-Pacific Breakthrough Therapy Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breakthrough Therapy Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breakthrough Therapy Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Breakthrough Therapy Drugs Market Size by Application
8.3.1 Asia-Pacific Breakthrough Therapy Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breakthrough Therapy Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breakthrough Therapy Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Breakthrough Therapy Drugs Market Size by Region
8.4.1 Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breakthrough Therapy Drugs Market Size (2016-2027)
9.2 Latin America Breakthrough Therapy Drugs Market Size by Type
9.2.1 Latin America Breakthrough Therapy Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Breakthrough Therapy Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Breakthrough Therapy Drugs Market Size by Type (2016-2027)
9.3 Latin America Breakthrough Therapy Drugs Market Size by Application
9.3.1 Latin America Breakthrough Therapy Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Breakthrough Therapy Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Breakthrough Therapy Drugs Market Size by Application (2016-2027)
9.4 Latin America Breakthrough Therapy Drugs Market Size by Country
9.4.1 Latin America Breakthrough Therapy Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Breakthrough Therapy Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breakthrough Therapy Drugs Market Size (2016-2027)
10.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Type
10.2.1 Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Application
10.3.1 Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country
10.4.1 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Breakthrough Therapy Drugs Introduction
11.1.4 Merck Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Breakthrough Therapy Drugs Introduction
11.2.4 Pfizer Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Breakthrough Therapy Drugs Introduction
11.3.4 AbbVie Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Breakthrough Therapy Drugs Introduction
11.5.4 Genentech Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.5.5 Genentech Recent Development
11.6 Gilead
11.6.1 Gilead Company Details
11.6.2 Gilead Business Overview
11.6.3 Gilead Breakthrough Therapy Drugs Introduction
11.6.4 Gilead Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.6.5 Gilead Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Breakthrough Therapy Drugs Introduction
11.7.4 Novartis Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Vertex Pharmaceuticals Incorporated
11.8.1 Vertex Pharmaceuticals Incorporated Company Details
11.8.2 Vertex Pharmaceuticals Incorporated Business Overview
11.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Introduction
11.8.4 Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2016-2021)
11.8.5 Vertex Pharmaceuticals Incorporated Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oncology
Table 3. Key Players of Anti-Viral
Table 4. Key Players of Neurology
Table 5. Key Players of Others
Table 6. Global Breakthrough Therapy Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breakthrough Therapy Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breakthrough Therapy Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Breakthrough Therapy Drugs Market Share by Regions (2016-2021)
Table 10. Global Breakthrough Therapy Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Breakthrough Therapy Drugs Market Share by Regions (2022-2027)
Table 12. Breakthrough Therapy Drugs Market Trends
Table 13. Breakthrough Therapy Drugs Market Drivers
Table 14. Breakthrough Therapy Drugs Market Challenges
Table 15. Breakthrough Therapy Drugs Market Restraints
Table 16. Global Breakthrough Therapy Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Breakthrough Therapy Drugs Market Share by Players (2016-2021)
Table 18. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy Drugs as of 2020)
Table 19. Ranking of Global Top Breakthrough Therapy Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Breakthrough Therapy Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breakthrough Therapy Drugs Product Solution and Service
Table 23. Date of Enter into Breakthrough Therapy Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Breakthrough Therapy Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Breakthrough Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Breakthrough Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Breakthrough Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Breakthrough Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Breakthrough Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Breakthrough Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Breakthrough Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Breakthrough Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Breakthrough Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Breakthrough Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Breakthrough Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breakthrough Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breakthrough Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Breakthrough Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Breakthrough Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Breakthrough Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Breakthrough Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Breakthrough Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Breakthrough Therapy Drugs Product
Table 66. Merck Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Breakthrough Therapy Drugs Product
Table 71. Pfizer Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Breakthrough Therapy Drugs Product
Table 76. AbbVie Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Bristol-Myers Squibb Company Company Details
Table 79. Bristol-Myers Squibb Company Business Overview
Table 80. Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product
Table 81. Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Company Recent Development
Table 83. Genentech Company Details
Table 84. Genentech Business Overview
Table 85. Genentech Breakthrough Therapy Drugs Product
Table 86. Genentech Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 87. Genentech Recent Development
Table 88. Gilead Company Details
Table 89. Gilead Business Overview
Table 90. Gilead Breakthrough Therapy Drugs Product
Table 91. Gilead Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 92. Gilead Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Breakthrough Therapy Drugs Product
Table 96. Novartis Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Vertex Pharmaceuticals Incorporated Company Details
Table 99. Vertex Pharmaceuticals Incorporated Business Overview
Table 100. Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2016-2021) & (US$ Million)
Table 101. Vertex Pharmaceuticals Incorporated Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breakthrough Therapy Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oncology Features
Figure 3. Anti-Viral Features
Figure 4. Neurology Features
Figure 5. Others Features
Figure 6. Global Breakthrough Therapy Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Services Case Studies
Figure 10. Breakthrough Therapy Drugs Report Years Considered
Figure 11. Global Breakthrough Therapy Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Breakthrough Therapy Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Breakthrough Therapy Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Breakthrough Therapy Drugs Market Share by Regions (2022-2027)
Figure 15. Global Breakthrough Therapy Drugs Market Share by Players in 2020
Figure 16. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Breakthrough Therapy Drugs Revenue in 2020
Figure 18. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Breakthrough Therapy Drugs Market Share by Type (2016-2027)
Figure 22. North America Breakthrough Therapy Drugs Market Share by Application (2016-2027)
Figure 23. North America Breakthrough Therapy Drugs Market Share by Country (2016-2027)
Figure 24. United States Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breakthrough Therapy Drugs Market Share by Type (2016-2027)
Figure 28. Europe Breakthrough Therapy Drugs Market Share by Application (2016-2027)
Figure 29. Europe Breakthrough Therapy Drugs Market Share by Country (2016-2027)
Figure 30. Germany Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breakthrough Therapy Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Breakthrough Therapy Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Breakthrough Therapy Drugs Market Share by Region (2016-2027)
Figure 40. China Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breakthrough Therapy Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Breakthrough Therapy Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Breakthrough Therapy Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breakthrough Therapy Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Breakthrough Therapy Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Breakthrough Therapy Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Breakthrough Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 63. Genentech Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 64. Gilead Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 66. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Breakthrough Therapy Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の画期的治療薬（BT）指定市場 2021：企業別、地域別、種類・用途別 The Breakthrough Therapy (BT) Designation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery Market Analysis and Insights: Global Drugs B…
- 世界のウイルス性結膜炎治療薬市場規模・現状・予測（2021年-2027年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
- 世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. Market Analysis and Insights: Global Drugs for Oncology Market The global Drugs for Oncology market size is …
- 世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. Market Analysis and Insights: Global Drugs for Oncology Market The global Drugs for Oncology market size is …